Recombinant Human Endostatin Durative Transfusion Combined With Pemetrexed Plus Cisplatin or Carboplatin in the First-line Treatment of Advanced Lung Adenocarcinoma With Wild-type EGFR or ALK-negative
Latest Information Update: 06 Nov 2021
Price :
$35 *
At a glance
- Drugs Endostatin (Primary) ; Carboplatin; Cisplatin; Pemetrexed
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- 30 Jun 2016 New trial record